These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16540027)

  • 21. [The cardiorenal syndrome: an emerging renal disease].
    Fabbian F
    G Ital Nefrol; 2007; 24(2):108. PubMed ID: 17458823
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal failure stages as predictors of mortality following acute coronary syndrome].
    Sanchez Hidalgo A; Pou M; Leiro R; López Gómez D; Martínez Ruiz M; Saurina A; Esteve V; Fulquet M; Ramírez de Arellano M; de Miguel M
    Nefrologia; 2009; 29(1):53-60. PubMed ID: 19240772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality.
    Damman K; Voors AA; Hillege HL; Navis G; Lechat P; van Veldhuisen DJ; Dargie HJ;
    Eur J Heart Fail; 2010 Sep; 12(9):974-82. PubMed ID: 20685688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?
    Schrier RW
    J Am Coll Cardiol; 2006 Jan; 47(1):1-8. PubMed ID: 16386657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ACE inhibitors for therapy of cardiac and kidney insufficiency].
    Schwaab B; Böhm M
    Dtsch Med Wochenschr; 2001 Jul; 126(28-29):831-2. PubMed ID: 11499268
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperkalemia risk and treatment of heart failure.
    Segura J; Ruilope LM
    Heart Fail Clin; 2008 Oct; 4(4):455-64. PubMed ID: 18760757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal disease: a common and a silent killer.
    de Zeeuw D
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S27-35. PubMed ID: 18580863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C; Wani M; Steward J; O'Mahony MS
    Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renal effect of treatment for heart failure].
    Rasmussen ZZ; Barfod T; Klit J
    Ugeskr Laeger; 2009 Feb; 171(9):718. PubMed ID: 19257999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography.
    de Silva R; Loh H; Rigby AS; Nikitin NP; Witte KK; Goode K; Bhandari S; Nicholson A; Clark AL; Cleland JG
    Am J Cardiol; 2007 Jul; 100(2):273-9. PubMed ID: 17631082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diuretics: principles and rules of use].
    Julien J
    Rev Prat; 1998 Apr; 48(8):913-8. PubMed ID: 11767340
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiorenal syndrome.
    Mahapatra HS; Lalmalsawma R; Singh NP; Kumar M; Tiwari SC
    Iran J Kidney Dis; 2009 Apr; 3(2):61-70. PubMed ID: 19395780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The case for dual Renin-Angiotensin system inhibition.
    Hirsch S
    Arch Intern Med; 2009 Nov; 169(20):1931; author reply 1931. PubMed ID: 19901153
    [No Abstract]   [Full Text] [Related]  

  • 37. The kidney in heart failure.
    Bellomo R; Ronco C
    Kidney Int Suppl; 1998 May; 66():S58-61. PubMed ID: 9573575
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in kidney function following heart failure treatment: focus on renin-angiotensin system blockade.
    Blankstein R; Bakris GL
    Heart Fail Clin; 2008 Oct; 4(4):425-38. PubMed ID: 18760754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in response to chronic heart failure therapies.
    Ghali JK; Lindenfeld J
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):555-65. PubMed ID: 18402544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diuretic therapy in heart failure].
    Splendiani G; Condò S
    G Ital Nefrol; 2006; 23 Suppl 34():S74-6. PubMed ID: 16634001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.